1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. InMode Ltd.
  6. News
  7. Summary
    INMD   IL0011595993

INMODE LTD.

(INMD)
  Report
Delayed Nasdaq  -  05/27 04:00:01 pm EDT
26.64 USD   +2.46%
05/23InMode to Participate at the UBS Healthcare One-on-One Virtual Day
PR
05/03Needham Adjusts InMode's Price Target to $58 From $82 on 'Peer Multiple Compression,' Reiterates Buy Rating
MT
05/02SECTOR UPDATE : Health Care Stocks Largely Sit Out Afternoon Recovery
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Health Care Stocks Finding Increased Support This Afternoon

10/13/2021 | 01:42pm EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
CANACCORD GENUITY GROUP INC. -1.27% 10.12 Delayed Quote.-32.89%
INMODE LTD. 2.46% 26.64 Delayed Quote.-62.26%
NASDAQ COMP. 3.33% 12131.13 Real-time Quote.-22.46%
NEURONETICS, INC. 11.67% 2.87 Delayed Quote.-35.65%
REGULUS THERAPEUTICS INC. 12.52% 0.31 Delayed Quote.-1.59%
RELAY THERAPEUTICS, INC. 3.46% 17.33 Delayed Quote.-43.57%
All news about INMODE LTD.
05/23InMode to Participate at the UBS Healthcare One-on-One Virtual Day
PR
05/03Needham Adjusts InMode's Price Target to $58 From $82 on 'Peer Multiple Compression,' R..
MT
05/02SECTOR UPDATE : Health Care Stocks Largely Sit Out Afternoon Recovery
MT
05/02SECTOR UPDATE : Health Care Stocks Sinking with Broader Monday Markets
MT
05/02Earnings Flash (INMD) INMODE Reports Q1 EPS $0.40, vs. Street Est of $0.38
MT
05/02Earnings Flash (INMD) INMODE Posts Q1 Revenue $85.9M, vs. Street Est of $83.5M
MT
05/02InMode Posts Higher Q1 Earnings, Sales
MT
05/02TRANSCRIPT : InMode Ltd., Q1 2022 Earnings Call, May 02, 2022
CI
05/02INMODE : Q1 Earnings Snapshot
AQ
05/02InMode Ltd. Provides Earnings Guidance for the Full Year Ending Dec. 31, 2022
CI
More news
Analyst Recommendations on INMODE LTD.
More recommendations
Financials (USD)
Sales 2022 417 M - -
Net income 2022 166 M - -
Net Debt 2022 - - -
P/E ratio 2022 13,8x
Yield 2022 -
Capitalization 2 213 M 2 213 M -
Capi. / Sales 2022 5,31x
Capi. / Sales 2023 4,78x
Nbr of Employees 362
Free-Float 82,5%
Chart INMODE LTD.
Duration : Period :
InMode Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INMODE LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 26,64 $
Average target price 55,50 $
Spread / Average Target 108%
EPS Revisions
Managers and Directors
Moshe Mizrahy Chairman & Chief Executive Officer
Yair Malca Chief Financial Officer
Michael Kreindel Chief Technology Officer & Director
Spero Theodorou Chief Medical Officer
Hadar Resnekov-Ron Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INMODE LTD.-62.26%2 213
THERMO FISHER SCIENTIFIC-19.05%224 053
DANAHER CORPORATION-19.00%190 779
INTUITIVE SURGICAL, INC.-36.22%82 258
SIEMENS HEALTHINEERS AG-14.49%67 624
EDWARDS LIFESCIENCES CORPORATION-21.95%62 872